期刊文献+

同型半胱氨酸与冠心病关系的探讨 被引量:4

Study on relation between plasma level of homocysteine and coronary heart disease
暂未订购
导出
摘要 目的 探讨同型半胱氨酸 (Hcy)水平与冠心病 (CHD)的关系。方法  187例住院患者 ,分为CHD组 93例及对照组 94例 ,测定Hcy水平与吸烟史、糖尿病、高血压、年龄、性别、脑梗死史、心肌梗死史、血脂各指标之间的关系。已行冠状动脉造影者按前降支、回旋支、右冠状动脉中任 1支血管狭窄≥ 5 0 %者诊为单支病变组 ,2支以上为多支病变组。任 1支血管狭窄 <5 0 %者诊为冠状动脉造影阴性组。冠心病的多个易患因素进行logistic回归分析。结果 Hcy水平 :(1)CHD组显著高于对照组 ;(2 )有心肌梗死史者高于无心肌梗死史者 ;(3)与吸烟史、高血压、糖尿病、脑梗死史、年龄、性别、血脂各指标之间无明显相关关系 ;(4 )多支病变组显著高于冠状动脉造影阴性组 ,单支病变组略高于冠状动脉造影阴性组 ;(5 )logistic回归分析示Hcy水平、吸烟、高血压是冠心病发病的危险因素。结论 Hcy水平升高与CHD密切相关 ,有心肌梗死史者Hcy水平增高明显 ;冠状动脉病变支数越多 ,血浆Hcy水平越高。 Objective To study the relation between plasma total homocysteine(Hcy) and coronary heart disease(CHD).Methods Ninety three CHD patients were enrolled as CHD group and ninety four non CHD patients as control group.The plasma levels of Hcy were measured in all subjects.The relations between Hcy and cigarette smoking,diabetes,hypertension,age,sex,cerebral infarction,myocardial infarction,blood lipid were analyzed.Patients with ≥50% stenosis in one of the three coronary vessels in coronary angiography were assigned to single vessel group,patients with two and three coronary vessel stenosis were assigned to multiple vessel group and patients with <50% stenosis in one coronary vessel constituted the negative group.The data of conventional risk factors of CHD were analyzed with logistic regression.Results (1)The level of Hcy in the patients with CHD was higher than that in the control group.(2)Hcy level in the patients with MI was higher than that in non MI subjects.(3)There were no relations between Hcy and cigarette smoking,diabetes,hypertension,age,sex,cerebral infarction and blood lipid.(4)Hcy level in multiple vessel group was significantly higher than that in negative group.The single vessel group presented slightly higher Hcy level than negative group.(5) Hcy level,cigarette smoking and hypertension were risk factors of CHD.Conclusions Plasma Hcy level is elevated in patients with CHD,particularly in cases of MI.Higher level of Hcy is associated with increased number of coronary arteries with stenosis.
出处 《中华老年心脑血管病杂志》 CAS 2002年第6期378-380,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 同型半胱氨酸 冠心病 危险因素 coronary disease cysteine
  • 相关文献

参考文献8

  • 1Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project[J].JAMA, 1997,277:1775-1781.
  • 2Boushey CJ, Beresfortt SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease [ J ]. JAMA,1995,274: 1049-1057.
  • 3Amesen E, Refsum H, Bonaa KH, et al. Serum total homocysteine and coronary heart diease[Jl. Int J Epidemiol, 1995,24:704-709.
  • 4Montalescot G, Ankri A, Chadefaux VB, et al. Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease[J]. N Eng J Med, 1997,337:230.
  • 5汤佩麟.冠心病患者血浆高半胱氨酸和血脂水平的关系[J].临床心血管病杂志,1998,14(2):76-78. 被引量:20
  • 6Glueck CF, Shaw P, Lang F, et al. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidenic patients[Jl. Am J Cardiol, 1995,75:132-135.
  • 7Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile[J]. JAMA, 1995,274:1526-1533.
  • 8Ubbink JB, Vermaak WJH, van der Merwe A, et al. Vitamin requirements for the treatment of hyperhomocysteinemia in humans[J]. J Nutr,1994, 124:1927-1933.

二级参考文献2

共引文献19

同被引文献27

  • 1[1]Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism[J]. J Clin Invest, 1976, 57 (4): 1079-1082
  • 2[2]Mayer EL, Robinson K, Jacobsen DW, et al. Low plasm homocysteine levels predict reduced atheroma burden in patient undergoing coronary interventions: Evidence from intravascular ultrasund [J]. J Am Coll Cardiol,1995, 25(special issum): 81A
  • 3[3]Genest JJ, Mcnamara JR, Salem DN, et al. Plasma hemocystiene levels in men with premature coronary artery disease [J]. J Am Coll Cardiol, 1990, 16 (5) :1114-1119
  • 4[6]Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia[J]. N Engl J Med, 1991, 324(17): 1149-1057
  • 5PetittiDB, Sideny S, BernsteinA, et al. Stroke in users of low-dose oral contracep tives[J]. N EnglJ Med,1995,335:8-15.
  • 6Tan CN, Venketassubramaniam N, Saw SM, et al. Hyperhomocystieinemia and risk of ischemic stroke among young Asian a- dults[J]. Stroke, 2002,33 : 1956- 1972.
  • 7Nygard O, Vollset SE, Refsum H, et al. Total plasma homo-cysteine and cardiovas- cular risk profile. The Hordaland Study[J]. Am Med Assos,1995:1526- 1533.
  • 8Wouters MG, Moorrees MT, van derMooren MJ, et al. Plasma homocysteine and meno- pausal staus[J]. Eur J Clin Invest,1995,25: 801 -805.
  • 9Brown CA, MckinneyKQ, YangKB, et al. The C677T metylenetrahydrofolate reduc- tase polymorphism influnce the homocys- teine-lowing effect of hormone replacement therapy[J]. Mol Gene Metab, 1999, 67: 43-48.
  • 10Olsewski AJ, MeCully KS. Homocysteine content of lipoprotein in hypercholestero lemia[J]. Atherosclerosis, 1991,88 : 61 - 68.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部